These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1650943)

  • 1. Chronic lead poisoning treated with dimercaptosuccinic acid.
    Grandjean P; Jacobsen IA; Jørgensen PJ
    Pharmacol Toxicol; 1991 Apr; 68(4):266-9. PubMed ID: 1650943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of chronic occupational lead poisoning with dimercaptosuccinic acid (DMSA)].
    Grandjean P; Jacobsen IA; Jørgensen PJ; Lings S; Andersen O
    Ugeskr Laeger; 1991 Oct; 153(41):2897-9. PubMed ID: 1659012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.
    Bradberry S; Vale A
    Clin Toxicol (Phila); 2009 Aug; 47(7):617-31. PubMed ID: 19663612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning.
    Bradberry S; Sheehan T; Vale A
    QJM; 2009 Oct; 102(10):721-32. PubMed ID: 19700440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Occupational lead poisoning treated with dimercaptosuccinic acid (DMSA) ( letter)].
    Sanz-Gallén P; Nogué S; Munné P; To J
    Rev Clin Esp; 1992 Jun; 191(1):58-9. PubMed ID: 1321469
    [No Abstract]   [Full Text] [Related]  

  • 6. [2,3-dimercaptosuccinic acid: a new chelating agent, safe and efficacious, for lead poisoning].
    Nogué S; Sanz-Gallén P; Munné P; To-Figueras J
    Med Clin (Barc); 1993 Oct; 101(12):478-9. PubMed ID: 8231377
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of meso-2,3-dimercaptosuccinic acid on urinary lead excretion in exposed men.
    Torres-Alanís O; Garza-Ocañas L; Piñeyro-López A
    Hum Exp Toxicol; 2002 Nov; 21(11):573-7. PubMed ID: 12507251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the effect of succimer (DMSA; dimercaptosuccinic acid) chelation therapy in patients poisoned by lead.
    van Eijkeren JC; Olie JD; Bradberry SM; Vale JA; de Vries I; Clewell HJ; Meulenbelt J; Hunault CC
    Clin Toxicol (Phila); 2017 Feb; 55(2):133-141. PubMed ID: 27919185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2,3-Dimercaptosuccinic acid as an antidote for lead intoxication.
    Graziano JH; Siris ES; LoIacono N; Silverberg SJ; Turgeon L
    Clin Pharmacol Ther; 1985 Apr; 37(4):431-8. PubMed ID: 2983924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of chelation therapy with succimer in young rabbits of moderate lead poisoning].
    Yu GY; Yan CH; Yu XG; Zuo Y; Zou XY; Xu J; Wu SH; Shen XM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jan; 43(1):8-13. PubMed ID: 19534872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disappearance of heme metabolites following chelation therapy with meso 2,3-dimercaptosuccinic acid (DMSA).
    Tutunji MF; al-Mahasneh QM
    J Toxicol Clin Toxicol; 1994; 32(3):267-76. PubMed ID: 8007034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Description of 3,180 courses of chelation with dimercaptosuccinic acid in children ≤ 5 y with severe lead poisoning in Zamfara, Northern Nigeria: a retrospective analysis of programme data.
    Thurtle N; Greig J; Cooney L; Amitai Y; Ariti C; Brown MJ; Kosnett MJ; Moussally K; Sani-Gwarzo N; Akpan H; Shanks L; Dargan PI
    PLoS Med; 2014 Oct; 11(10):e1001739. PubMed ID: 25291378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning.
    Bradberry S; Vale A
    Clin Toxicol (Phila); 2009 Nov; 47(9):841-58. PubMed ID: 19852620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.
    Smith D; Bayer L; Strupp BJ
    Environ Res; 1998 Aug; 78(2):168-76. PubMed ID: 9719621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rash and pyrexia after succimer (dimercaptosuccinic acid; DMSA).
    Varma A; Bradberry SM; Vale JA
    Clin Toxicol (Phila); 2017 Aug; 55(7):680. PubMed ID: 28349748
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of 2,3 dimercaptosuccinic acid in the treatment of lead poisoning in adults.
    Lifshitz M; Hashkanazi R; Phillip M
    Ann Med; 1997 Feb; 29(1):83-5. PubMed ID: 9073328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramuscular administration of iron during long-term chelation therapy with 2,3-dimercaptosuccinic acid in a man with severe lead poisoning.
    Haust HL; Inwood M; Spence JD; Poon HC; Peter F
    Clin Biochem; 1989 Jun; 22(3):189-96. PubMed ID: 2544323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term efficacy of oral dimercaptosuccinic acid in children with low to moderate lead intoxication.
    Besunder JB; Anderson RL; Super DM
    Pediatrics; 1995 Oct; 96(4 Pt 1):683-7. PubMed ID: 7567330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impacts of lead exposure and chelation therapy on bone metabolism during different developmental stages of rats.
    Zhang Y; Zhou L; Li S; Liu J; Sun S; Ji X; Yan C; Xu J
    Ecotoxicol Environ Saf; 2019 Nov; 183():109441. PubMed ID: 31404725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of dimercaptosuccinic acid and calcium disodium ethylenediaminetetraacetic acid versus dimercaptopropanol and ethylenediaminetetraacetic acid in children with lead poisoning.
    Besunder JB; Super DM; Anderson RL
    J Pediatr; 1997 Jun; 130(6):966-71. PubMed ID: 9202621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.